Blast counts and cytogenetics performed on bone marrow aspirations while patient was on and off G-CSF
| Date (1999) . | G-CSF μg/kg/d . | Blasts (%) . | Karyotype . | NE/ELA-2 . | G-CSF-R . |
|---|---|---|---|---|---|
| March 17 | 10 | 5 | 46,XY (22) | ||
| June 8 | 10 | 73 | 46,XY, add (18) (q23) (18) | ||
| 46,XY (2) | |||||
| July 2 | 0 | 2 | 46,XY (20) | Abnormal | Abnormal |
| August 26 | 0 | 1 | 46,XY (20) | Abnormal | Abnormal |
| October 18 | 6 | 40 | 46,XY, add (18) (q23) (4) | ||
| 47,XY, add (18) (q23), +21 (2) | |||||
| 46,XY (13) | |||||
| November 1 | 0 | 1 | 46,XY, add (18) (q23), i(21) (q10) (5) | ||
| 46,XY, add (17) (q25), add (18) (q23) (2) | |||||
| 46,XY (17) | |||||
| November 29 | 0 | 1 | 46,XY, add (18) (q23), i(21), (q10) (2) | ||
| 46,XY, add (18) (q23) (1) | |||||
| 46,XY (17) | |||||
| Post-transplantation day 100 | 0 | 46,XX (20) | Normal | Normal |
| Date (1999) . | G-CSF μg/kg/d . | Blasts (%) . | Karyotype . | NE/ELA-2 . | G-CSF-R . |
|---|---|---|---|---|---|
| March 17 | 10 | 5 | 46,XY (22) | ||
| June 8 | 10 | 73 | 46,XY, add (18) (q23) (18) | ||
| 46,XY (2) | |||||
| July 2 | 0 | 2 | 46,XY (20) | Abnormal | Abnormal |
| August 26 | 0 | 1 | 46,XY (20) | Abnormal | Abnormal |
| October 18 | 6 | 40 | 46,XY, add (18) (q23) (4) | ||
| 47,XY, add (18) (q23), +21 (2) | |||||
| 46,XY (13) | |||||
| November 1 | 0 | 1 | 46,XY, add (18) (q23), i(21) (q10) (5) | ||
| 46,XY, add (17) (q25), add (18) (q23) (2) | |||||
| 46,XY (17) | |||||
| November 29 | 0 | 1 | 46,XY, add (18) (q23), i(21), (q10) (2) | ||
| 46,XY, add (18) (q23) (1) | |||||
| 46,XY (17) | |||||
| Post-transplantation day 100 | 0 | 46,XX (20) | Normal | Normal |